News & Analysis on Clinical Trial Services & Contract Research And Development
Despite Sanofi’s “conflicted” management and subsequent abandonment of Afrezza, the market opportunity for inhaled insulin is still huge, according to Dance Biopharm's CEO.
Experts agree that CROs will be more connected in 2016, however limitations – and hesitations – still surround remote based monitoring.
After securing partnerships with AbbVie and Sanofi, Unilife has announced another exclusive agreement for a wearable injector device with Amgen.
Medidata expects to become a strategic partner to even more pharma firms as Boehringer Ingelheim becomes the latest to transition to its cloud technology platform.
In 2016 clinical trial and real-world data will become increasingly important in the decision to prescribe medicine, Parexel President and COO Mark Goldberg told Outsourcing-Pharma.com.
Waters Corporation will offer an open access analytical laboratory and technology support to biotechs based at a former AstraZeneca site in the UK.